SCYNEXIS, Inc(NASDAQ:SCYX) 
SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, i...
Website: http://www.scynexis.com
Full Time Employees: 27
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.86
H 0.91
L 0.82
C 0.84
V 202,364
10EMA 0.84
20EMA 0.84
60EMA 0.84
120EMA 0.84
250EMA 0.84